Grant of Interim Extension of the Term of U.S. Patent No. 9,364,354; Reducer®, 32361 [2020-11626]
Download as PDF
<![CDATA[
jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 85, No. 104 / Friday, May 29, 2020 / Notices
conduct a marine Geological and
Geophysical seismic survey in the
Atlantic Ocean. This matter constitutes
an appeal of an ‘‘energy project’’ within
the meaning of the CZMA regulations,
see 15 CFR 930.123(c).
Under the CZMA, the Secretary may
override the North Carolina Division of
Coastal Management’s objection on
grounds that the project is consistent
with the objectives or purposes of the
CZMA, or is necessary in the interest of
national security. To make the
determination that the proposed activity
is ‘‘consistent with the objectives or
purposes of the CZMA,’’ the Department
must find that: (1) The proposed activity
furthers the national interest as
articulated in sections 302 or 303 of the
CZMA, in a significant or substantial
manner; (2) the national interest
furthered by the proposed activity
outweighs the activity’s adverse coastal
effects, when those effects are
considered separately or cumulatively;
and (3) no reasonable alternative is
available that would permit the
proposed activity to be conducted in a
manner consistent with the enforceable
policies of the applicable coastal
management program. 15 CFR 930.121.
To make the determination that the
proposed activity is ‘‘necessary in the
interest of national security,’’ the
Secretary must find that a national
defense or other national security
interest would be significantly impaired
if the proposed activity is not permitted
to go forward as proposed. 15 CFR
930.122.
On March 30, 2020, NOAA published
a Federal Register Notice announcing
closure of the appeal decision record. 85
FR 17539. Under the CZMA, a final
decision on the appeal must be issued
no later than 60 days after notice
announcing closure of the decision
record is published. 16 U.S.C.
1465(b)(3). This deadline may be
extended, however, by publishing
(within the 60-day period) a subsequent
notice explaining why a decision cannot
be issued within that time frame. 16
U.S.C. 1465(c)(1). In that event, a final
decision must be issued no later than 15
days after the date of publication of the
subsequent notice. 16 U.S.C. 1465(c)(2).
This announcement provides notice
that the deadline for issuing a decision
on this appeal has been extended by 15
days. The additional time is needed to
complete a review of the record and
reach a decision. A decision on the
federal consistency appeal will be
issued no later than June 15, 2020.
VerDate Sep<11>2014
17:06 May 28, 2020
Jkt 250001
(Authority Citation: 16 U.S.C. 1465(c); 15
CFR 930.130(b))
Adam Dilts,
Chief, Oceans and Coasts Section, NOAA
Office of General Counsel.
[FR Doc. 2020–11341 Filed 5–28–20; 8:45 am]
BILLING CODE 3510–JE–P
DEPARTMENT OF COMMERCE
Patent and Trademark Office
[Docket No. PTO–P–2020–0028]
Grant of Interim Extension of the Term
of U.S. Patent No. 9,364,354; Reducer®
United States Patent and
Trademark Office, Department of
Commerce.
ACTION: Notice of interim patent term
extension.
AGENCY:
The United States Patent and
Trademark Office has issued an order
granting interim extension for a oneyear interim extension of the term of
U.S. Patent No. 9,364,354.
FOR FURTHER INFORMATION CONTACT: Ali
Salimi by telephone at (571) 272–0909;
by mail marked to his attention and
addressed to the Commissioner for
Patents, Mail Stop Hatch-Waxman PTE,
P.O. Box 1450, Alexandria, VA 22313–
1450; by fax marked to his attention at
(571) 273–0909; or by email to
ali.salimi@uspto.gov.
SUPPLEMENTARY INFORMATION: Section
156 of Title 35, United States Code,
generally provides that the term of a
patent may be extended for a period of
up to five years if the patent claims a
product, or a method of making or using
a product, that has been subject to
certain defined regulatory review, and
that the patent may be extended for
interim periods of up to one year if the
regulatory review is anticipated to
extend beyond the expiration date of the
patent.
On May 21, 2020, Neovasc Medical
Ltd., the patent owner of record, timely
filed an application under 35 U.S.C.
156(d)(5) for an interim extension of the
term of U.S. Patent No. 9,364,354. The
patent claims the catheter implantable
device, Reducer®. The application for
patent term extension indicates that a
Premarket Approval Application (PMA)
P190035 was submitted to the Food and
Drug Administration (FDA) on
December 31, 2019.
Review of the patent term extension
application indicates that, except for
permission to market or use the product
commercially, the subject patent would
be eligible for an extension of the patent
term under 35 U.S.C. 156, and that the
SUMMARY:
PO 00000
Frm 00006
Fmt 4703
Sfmt 4703
32361
patent should be extended for one year
as required by 35 U.S.C. 156(d)(5)(B).
Because the regulatory review period
will continue beyond the original
expiration date of the patent, June 6,
2020, interim extension of the patent
term under 35 U.S.C. 156(d)(5) is
appropriate.
An interim extension under 35 U.S.C.
156(d)(5) of the term of U.S. Patent No.
9,364,354 is granted for a period of one
year from the original expiration date of
the patent.
Robert Bahr,
Deputy Commissioner for Patent Examination
Policy, United States Patent and Trademark
Office.
[FR Doc. 2020–11626 Filed 5–28–20; 8:45 am]
BILLING CODE 3510–16–P
DEPARTMENT OF COMMERCE
Patent and Trademark Office
Agency Information Collection
Activities; Submission to the Office of
Management and Budget (OMB) for
Review and Approval; Comment
Request; Native American Tribal
Insignia Database
The United States Patent and
Trademark Office (USPTO) will submit
the following information collection
request to the Office of Management and
Budget (OMB) for review and clearance
in accordance with the Paperwork
Reduction Act of 1995, on or after the
date of publication of this notice. The
USPTO invites the general public and
other Federal agencies to comment on
proposed, and continuing information
collections, which helps the USPTO
assess the impact of its information
collection requirements and minimize
the public’s reporting burden. Public
comments were previously requested
via the Federal Register on March 16,
2020 during a 60-day comment period.
This notice allows for an additional 30
days for public comments.
Agency: United States Patent and
Trademark Office, Department of
Commerce.
Title: Native American Tribal Insignia
Database
OMB Control Number: 0651–0048.
Form Number(s): None.
Type of Request: Extension and
revision of a currently approved
information collection.
Number of Respondents: 5
respondents.
Average Hours per Response: The
USPTO estimates that a recognized
Native American tribe will require an
average of 1 hour to complete a request
to record an official insignia, including
E:\FR\FM\29MYN1.SGM
29MYN1
]]>Agencies
[Federal Register Volume 85, Number 104 (Friday, May 29, 2020)]
[Notices]
[Page 32361]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-11626]
-----------------------------------------------------------------------
DEPARTMENT OF COMMERCE
Patent and Trademark Office
[Docket No. PTO-P-2020-0028]
Grant of Interim Extension of the Term of U.S. Patent No.
9,364,354; Reducer[supreg]
AGENCY: United States Patent and Trademark Office, Department of
Commerce.
ACTION: Notice of interim patent term extension.
-----------------------------------------------------------------------
SUMMARY: The United States Patent and Trademark Office has issued an
order granting interim extension for a one-year interim extension of
the term of U.S. Patent No. 9,364,354.
FOR FURTHER INFORMATION CONTACT: Ali Salimi by telephone at (571) 272-
0909; by mail marked to his attention and addressed to the Commissioner
for Patents, Mail Stop Hatch-Waxman PTE, P.O. Box 1450, Alexandria, VA
22313-1450; by fax marked to his attention at (571) 273-0909; or by
email to [email protected].
SUPPLEMENTARY INFORMATION: Section 156 of Title 35, United States Code,
generally provides that the term of a patent may be extended for a
period of up to five years if the patent claims a product, or a method
of making or using a product, that has been subject to certain defined
regulatory review, and that the patent may be extended for interim
periods of up to one year if the regulatory review is anticipated to
extend beyond the expiration date of the patent.
On May 21, 2020, Neovasc Medical Ltd., the patent owner of record,
timely filed an application under 35 U.S.C. 156(d)(5) for an interim
extension of the term of U.S. Patent No. 9,364,354. The patent claims
the catheter implantable device, Reducer[supreg]. The application for
patent term extension indicates that a Premarket Approval Application
(PMA) P190035 was submitted to the Food and Drug Administration (FDA)
on December 31, 2019.
Review of the patent term extension application indicates that,
except for permission to market or use the product commercially, the
subject patent would be eligible for an extension of the patent term
under 35 U.S.C. 156, and that the patent should be extended for one
year as required by 35 U.S.C. 156(d)(5)(B). Because the regulatory
review period will continue beyond the original expiration date of the
patent, June 6, 2020, interim extension of the patent term under 35
U.S.C. 156(d)(5) is appropriate.
An interim extension under 35 U.S.C. 156(d)(5) of the term of U.S.
Patent No. 9,364,354 is granted for a period of one year from the
original expiration date of the patent.
Robert Bahr,
Deputy Commissioner for Patent Examination Policy, United States Patent
and Trademark Office.
[FR Doc. 2020-11626 Filed 5-28-20; 8:45 am]
BILLING CODE 3510-16-P
